Chapter 36. Chapter 36

Introduction

Problem-Solving Video Assessment
true
false

Chapter 36 Problem-Solving Video Assessment

The drug favipiravir has shown promise as an antiviral therapy in mouse models of Ebola virus infection. Researchers believe it works by inhibiting the RNA-dependent RNA polymerase of Ebola. You would like to test this hypothesis by directly measuring how well favipiravir inhibits this polymerase in vitro. To do so, you measure RNA polymerase activity with the nucleotide substrate present at a concentration equal to twice its KM value. The results of the assay are below:

Favipiravir (μm) Units of RNA polymerase activity
0 80.4
0.5 72.5
1 65.6
1.5 61.8
2 53.3
5 47.9
10 40.2
25 21.1
50 11.2
100 8.4
Table

Question 36.1

leOdwy4hrsIUHogejyev88cgpfRDXoDrgs6N38KkDNEYlxUDETbQRXimmjjGDGJEEmVyEj3A5FtH/on7sQsjpKCBv9oZ1N5gUDM/plQ6VVciFfsn+TqNuw2H24tuKVkIdPpmVWrYxxjQc3QExVCMuS4Qw6aPr6CYqZ46wfHh0q9EYX8q9fNtxH5OnQI7BWACuzKs6NTx8QiGN+79qguioV3Mlss=
_feedback_correct: Correct. _feedback_incorrect: Incorrect.

Question 36.2

V6tuKOk/KD58QEf41z/SeXT+7tDWJYPLgw3WkjcR6gYGKI/3TDJW/t39DNrPQrAhSa/ITx3FVrRsTL1cIuWn05aYCZB+cd1D8Ia/6TlLdwImluN7o+Bi8G9Ft/psrDmDhDDI9YO8D9L8gQAL+wOs8X0I8Kcj0p9UgO3ukoClhzwTLcr1iOaUGt9qRL9TemMdMqVEcVVj44iycIsauPUY4qf4RGLHhJFM
_feedback_correct: Correct. _feedback_incorrect: Incorrect.

Question 36.3

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
_feedback_correct: Correct. _feedback_incorrect: Incorrect.

Activity results are being submitted...